Warfarin treatment in stent thrombosis

Arslan A., Eyuboglu M., Alpaslan E., ERGENE A. O.

Gynecologic Oncology Reports, vol.2, no.2, pp.96-97, 2016 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 2 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.1016/j.ijcac.2016.05.001
  • Journal Name: Gynecologic Oncology Reports
  • Journal Indexes: Scopus
  • Page Numbers: pp.96-97
  • Keywords: IVUS, Stent thrombosis, Warfarin
  • Dokuz Eylül University Affiliated: Yes


© 2016 Elsevier B.V.A 62 year-old male patient was admitted to the hospital due to anterior ST segment elevated myocardial infarction. Thrombotic complication developed three times during the hospitalization after primary percutaneous coronary intervention (PCI). Instent thrombus was identified despite the optimal medical therapy, new antiplatelet agents and intravascular ultrasound guided PCI. Therefore, symptoms were controlled with warfarin + clopidogrel treatment. At the third month of warfarin + clopidogrel treatment, the patient was asymptomatic and no active electrocardiographic changes were observed. Stent thrombosis developing under new antiplatelet agents constitutes a great problem and there are no clear data for the solution. We described an interesting case in which we achieved symptomatic control by warfarin + clopidogrel in the stent thrombosis developing during the treatment with dual antiplatelet therapy.